Levodopa + Benserazide (Levodopa + Benserazide)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLevodopa + BenserazideLevodopa + Benserazide
Similar drugsTo uncover
  • Levodopa + Benserazide
    capsules inwards 
    IZVARINO PHARMA, LLC     Russia
  • Levodopa / Benserazid-Teva
    pills inwards 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Madopar® "125"
    capsules inwards 
    Hoffmann-La Roche Ltd.     Switzerland
  • Madopar® "250"
    pillscapsules inwards 
    Hoffmann-La Roche Ltd.     Switzerland
  • Madopar®GSS "125"
    capsules inwards 
    Hoffmann-La Roche Ltd.     Switzerland
    • Dosage form: & nbspcapsules
    ATX: & nbsp

    N.04.B.A   Dopa and dopa derivatives

    N.04.B.A.02   Levodopa and a decarboxylase inhibitor

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004505
    Date of registration:25.10.2017
    Expiration Date:25.10.2022
    The owner of the registration certificate:IZVARINO PHARMA, LLC IZVARINO PHARMA, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.11.2017
    Illustrated instructions
      Instructions
      Up